Literature DB >> 8217107

Clinical use of bone allografts.

H T Aro1, A J Aho.   

Abstract

Modern techniques of bone allograft surgery provide a treatment modality for management of difficult skeletal defects. In oncological limb-salvage surgery, allograft reconstructions permit re-establishment of skeletal continuity and function after a wide resection of bone tumour. Bone allografts are increasingly used in salvage of difficult bone stock deficiencies following failed total joint replacements. Union between the allograft and the host bone takes place slowly and the use of autogenous bone graft at the graft-host junction is recommended for induction of repair. Internal repair (revascularization and substitution of the original graft bone with new host bone) also progresses slowly and seems to be confined only to the superficial surface and the ends of the graft. Biomechanically, a massive allograft may serve a structural function in the absence of advanced revascularization and creeping substitution processes. Infection of an allograft is a disastrous complication, whereas non-union of the graft-host junction and fracture of the graft are amenable to surgical treatment. Osteochondral allografts tend to show gradual deterioration of the articular cartilage with time, necessitating occasionally late resurfacing arthroplasty. It is evident that there is more active immune response to osteochondral grafts than was thought previously. Bone allografts induce cell-mediated and antibody-mediated cytotoxicity specific for donor antigens similar to that seen after organ transplantations. Not only the basic mechanisms of bone allograft rejection but also the clinical features of bone allograft rejection are poorly characterized. Clinically, new non-invasive imaging techniques should be applied in determining the metabolic activity of bone in order to find the optimal loading of healing allografts. Although the clinical results of massive bone allografts are still not completely predictable, the method has proved to be a technically and biologically feasible alternative for non-biological skeletal reconstructions.

Entities:  

Mesh:

Year:  1993        PMID: 8217107     DOI: 10.3109/07853899309147303

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  20 in total

1.  Bacterial colonization of bone allografts: establishment and effects of antibiotics.

Authors:  Constantinos Ketonis; Stephanie Barr; Christopher S Adams; Noreen J Hickok; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

2.  Antibacterial activity of bone allografts: comparison of a new vancomycin-tethered allograft with allograft loaded with adsorbed vancomycin.

Authors:  Constantinos Ketonis; Stephanie Barr; Irving M Shapiro; Javad Parvizi; Christopher S Adams; Noreen J Hickok
Journal:  Bone       Date:  2010-10-28       Impact factor: 4.398

3.  Historic and current strategies in bone tissue engineering: do we have a hope in Hench?

Authors:  Eileen Gentleman; Julia M Polak
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

4.  Interactions of total bone marrow cells with increasing quantities of macroporous calcium phosphate ceramic granules.

Authors:  Damien Le Nihouannen; Laure Duval; Antoine Lecomte; Marion Julien; Jérôme Guicheux; Guy Daculsi; Pierre Layrolle
Journal:  J Mater Sci Mater Med       Date:  2007-06-07       Impact factor: 3.896

Review 5.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

6.  A simple critical-sized femoral defect model in mice.

Authors:  Bret H Clough; Matthew R McCarley; Carl A Gregory
Journal:  J Vis Exp       Date:  2015-03-15       Impact factor: 1.355

7.  An allograft generated from adult stem cells and their secreted products efficiently fuses vertebrae in immunocompromised athymic rats and inhibits local immune responses.

Authors:  Bret H Clough; Eoin P McNeill; Daniel Palmer; Ulf Krause; Thomas J Bartosh; Christopher D Chaput; Carl A Gregory
Journal:  Spine J       Date:  2016-10-17       Impact factor: 4.166

8.  Does total humeral endoprosthetic replacement provide reliable reconstruction with preservation of a useful extremity?

Authors:  Hazem Wafa; Krishna Reddy; Robert Grimer; Adesegun Abudu; Lee Jeys; Simon Carter; Roger Tillman
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

9.  HLA sensitization and allograft bone graft incorporation.

Authors:  William G Ward; Michael D Gautreaux; Dylan C Lippert; Carol Boles
Journal:  Clin Orthop Relat Res       Date:  2008-05-28       Impact factor: 4.176

Review 10.  Consolidation of massive bone allografts in limb-preserving operations for bone tumours.

Authors:  M San Julian Aranguren; M Leyes; G Mora; J Cañadell
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.